Non-small cell lung cancer (NSCLC) accounts for 85% of lung cancer cases, yet the 5-year survival rate is just 20%. We’re working to change that by advancing novel therapies and potentially giving patients with #LungCancer more time with their families. See how we're getting #InFrontofCancer: https://lnkd.in/g8M4UNrg #JNJOncology #LungCancerAwarenessMonth
In 1907, Metchnikoff published that aging starts in the microbiome. In 2012, We filed the first provisional patent for a treatment based on the longevity of Jeanne Calment. We need J&J to invest in us. …In a real longevity solution Too much noise is missing the truth. Aging is a disease state. Multiple factors contribute to rates of aging. Our FDA cleared treatment actually halts it. The best longevity solution is prevention. Link: Nextrin.com Summary: We’ve shown that aging is due to rogue gut bacteria consuming the body’s intake of proteins. Aging is a parasitic condition. FYI Only Pitch Deck: https://docsend.com/view/pze9uhybtw9tiu8w
Encouraging screening for at-risk individuals and communities will reduce lung cancer rates